Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Mar. Drugs 2009, 7(2), 258-267; doi:10.3390/md7020258
Article

Expression, Purification and Bioactivities Analysis of Recombinant Active Peptide from Shark Liver

1,2, 1, 1, 2, 1 and 1,*
Received: 20 April 2009; in revised form: 13 June 2009 / Accepted: 13 June 2009 / Published: 22 June 2009
(This article belongs to the Special Issue Alkaloid Analogs)
View Full-Text   |   Download PDF [1277 KB, uploaded 22 June 2009]
Abstract: The Active Peptide from Shark Liver (APSL) was expressed in E. coli BL21 cells. The cDNA encoding APSL protein was obtained from shark regenerated hepatic tissue by RT-PCR, then it was cloned in the pET-28a expression vector. The expressed fusion protein was purified by Ni-IDA affinity chromatography. SDS-PAGE and HPLC analysis showed the purity of the purified fusion protein was more than 98%. The recombinant APSL (rAPSL) was tested for its biological activity both in vitro, by its ability to improve the proliferation of SMMC7721 cells, and in vivo, by its significant protective effects against acute hepatic injury induced by CCl4 and AAP (acetaminophen) in mice. In addition, the rAPSL could decrease the blood glucose concentration of mice with diabetes mellitus induced by alloxan. Paraffin sections of mouse pancreas tissues showed that rAPSL (3 mg/kg) could effectively protect mouse islets from lesions induced by alloxan, which indicated its potential application in theoretical research and industry.
Keywords: APSL; prokaryotic expression; bioactivity analysis APSL; prokaryotic expression; bioactivity analysis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Lv, Z.; Ou, Y.; Li, Q.; Zhang, W.; Ye, B.; Wu, W. Expression, Purification and Bioactivities Analysis of Recombinant Active Peptide from Shark Liver. Mar. Drugs 2009, 7, 258-267.

AMA Style

Lv Z, Ou Y, Li Q, Zhang W, Ye B, Wu W. Expression, Purification and Bioactivities Analysis of Recombinant Active Peptide from Shark Liver. Marine Drugs. 2009; 7(2):258-267.

Chicago/Turabian Style

Lv, Zhengbing; Ou, Yu; Li, Qian; Zhang, Wenping; Ye, Boping; Wu, Wutong. 2009. "Expression, Purification and Bioactivities Analysis of Recombinant Active Peptide from Shark Liver." Mar. Drugs 7, no. 2: 258-267.


Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert